36530 Federal Register / Vol. 71, No.
123 / Tuesday, June 27, 2006 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Planning Grants to
Develop CAM Research at Minority Serving
Institutions.
Date: July 6, 2006.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Alternative Medicine, NIH, 6707
Democracry Boulevard, Suite 401, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Dale L. Birkle, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 451–6570,
birkled@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Clinical Research.
Date: July 7, 2006.
Time: 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Alternative Medicine, NIH, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Jeanette M. Hosseini, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 594–9096,
jeanetteh@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Dated: June 15, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5690 Filed 6–26–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
sroberts on PROD1PC70 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
VerDate Aug<31>2005 17:33 Jun 26, 2006 Jkt 208001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
child Health and Human Development Initial
Review Group, Biobehavioral and Behavioral
Sciences Subcommittee.
Date: July 10–11, 2006.
Time: 9 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Washington, Pennsylvania
Ave. at 15th Street, NW., Washington, DC
20004.
Contact Person: Marita R. Hopmann, PhD.,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892, (301) 435–6911,
hopmannm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: June 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5683 Filed 6–26–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel, ‘‘Stress and
Aging’’.
Date: July 6, 2006.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health/NIA,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Alicja L. Markowska, PhD.,
DSC, Scientific Review Office, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite
2C212, 301–496–9666,
markowsa@nia.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Aging and
Bone.
Date: July 10, 2006.
Time: 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
2C212, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Alicja L. Markowska, PhD.,
DSC, Scientific Review Office, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–496–9666,
markowsa@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Anemia and
Aging.
Date: July 11–12, 2006.
Time: 4 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Alicja L. Markowska, PhD.,
DSC, Scientific Review Office, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–496–9666,
markowsa@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, ‘‘Aging
Cognitive Decline and Ad’’.
Date: July 11–12, 2006.
Time: 7 p.m. to 11 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Chevy Chase, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Louise L. Hsu, PhD, Health
Scientist Administrator, Scientific Review
Office, National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue/Suite 2C–
212, Bethesda, MD 20892, (301) 496–7705,
hsul@exmur.nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer’s
Disease Clinical Trials.
Date: July 12, 2006.
Time: 1 p.m. to 2 p.m.
27JNN1
 Federal Register / Vol. 71, No. 123 / Tuesday, June 27, 2006 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 28014 (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer’s
Disease Clinical Trials.
Date: July 12, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer’s
Disease Clinical Trials.
Date: July 12, 2006.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Health and
Aging.
Date: July 25, 2006.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 28014 (Telephone Conference
Call).
Contact Person: William Cruce, PhD,
Health Scientist Administrator, Scientific
Review Office, National Institute on Aging,
National Institutes of Health, Room 2C–212,
7201 Wisconsin Avenue, Bethesda, MD
20814, 301–402–7704, crucew@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: June 19, 2006.
sroberts on PROD1PC70 with NOTICES
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5685 Filed 6–26–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005 19:44 Jun 26, 2006 Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, NEUROAIDS SNRP UPR.
Date: June 22–23, 2006.
Time: 7:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel El Confento, 100 Cristo Street,
Old San Juan, Puerto Rico 00901.
Contact Person: Phillip F. Wiethorn,
Scientific Review Administrator, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard,
MSC 9529, Neuroscience Center, Room 3203,
Bethesda, MD 20892–9529, (301) 496–5388,
wiethorp@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: June 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5686 Filed 6–26–06; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
imaging and bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM
36531
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, ZEB1 OSR C 01
2006 Quantum Grants.
Date: July 17–18, 2006.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Clarion Hotel Bethesda Park, 8400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Prabha L. Atreya, PhD.,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
Biomedical Imaging, and Bioengineering,
Bethesda, MD 20892, (301) 496–8633,
atreyapr@mail.nih.gov.
Dated: June 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5688 Filed 6–26–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases, Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Lymphocyte Survival and
Death.
27JNN1